Try GOLD - Free
UK to scale up production of mRNA vaccines
Bio Spectrum
|BioSpectrum India Nov 2024
Scientists at the University of Sheffield, in the United Kingdom (UK), will receive up to £3.7 million ($4.8 million) from Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) to establish proof-of-concept for RNAbox, a specialised process designed to scale up production of messenger RNA (mRNA) vaccines at regional vaccine manufacturing sites.
-
The easily adaptable and automated process aims to improve the world’s pandemic readiness by helping to increase equitable access to future doses of different mRNA vaccines as and when needed. It also has the potential to speed up our response to future emerging outbreaks, containing them before they
This story is from the BioSpectrum India Nov 2024 edition of Bio Spectrum.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Bio Spectrum
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025
Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025
Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Bio Spectrum
Al/loT-Driven Real-time Cardiac Event Prediction & Treatment
It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.
2 mins
September 2025
Bio Spectrum
SCHOTT announces launch of syringe and cartridge glass tubing in India
SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.
1 min
September 2025
Bio Spectrum
ICMR expands collaborative partnership with CEPI for vaccine research
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Indian Council of Medical Research (ICMR) have expanded their collaborative partnership through a newly signed Memorandum of Understanding (MOU).
1 min
September 2025
Bio Spectrum
AMTZ to open India's first advanced 3D printing hub for orthopaedic implants
In a landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) have announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility powered by 3D printing and precision engineering.
1 min
September 2025
Bio Spectrum
Alveolus Bio secures strategic investment from Shilpa Medicare
Alveolus Bio, a US-based respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, has announced a strategic financing round led by Raichur-based Shilpa Medicare, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
1 min
September 2025
Bio Spectrum
JNCASR explores potential cure for Alzheimer's Disease
Researchers from Bengaluru-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the Department of Science and Technology (DST) have explored altered miRNAs in the Alzheimer's Disease (AD) brain and also probed the potential of miRNAs to be biomarkers for early, specific and accurate clinical diagnosis of AD.
1 min
September 2025
Bio Spectrum
Aster DM Healthcare to inject Rs 580 Cr to build 5th hospital in Bengaluru
Aster DM Healthcare, one of India's leading integrated healthcare providers, in a move to strengthen its footprint in one of India's fastest-growing healthcare hubs, Bengaluru, has announced Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025
Listen
Translate
Change font size